secwatch.observer — SEC 8-K summary
======================================

Issuer:     ABVC BIOPHARMA, INC. (ABVC)
CIK:        0001173313
Form:       8-K
Filed at:   2024-07-12T23:59:59+00:00
Accession:  0001213900-24-061028
Event type: regulatory
Sentiment:  negative
Materiality: 0.65
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

ABVC BioPharma receives Nasdaq deficiency notice for bid price below $1.00
--------------------------------------------------------------------------

- Received Nasdaq notice on July 10, 2024 for non-compliance with minimum $1.00 bid price rule over 30 consecutive days.
- Compliance deadline is January 6, 2025; can regain if bid price closes at $1.00+ for 10 business days.
- If not cured, may qualify for additional 180-day period if other initial listing standards are met.
- Company may consider a reverse stock split to cure the deficiency.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1173313/000121390024061028/0001213900-24-061028-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1173313/000121390024061028/ea0209346-8k_abvcbio.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-061028

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer